临床药师参与长期使用糖皮质激素患者药学监护的效果分析

Abstract
Figure/Table
References (20)
Related Citation (15)

Download: PDF (0 KB) HTML (36 KB)
Export: BibTeX | EndNote (RIS)

Abstract objective To explore the role of clinical pharmacists in long-term treatment with Glucocorticoids patients through pharmaceutical care. Methods A total of 80 patients with nephrotic syndrome or systemic lupus erythematosus with long-term use of Glucocorticoids in Heyuan People′s Hospital from June 2018 to December 2019 were randomly selected. The patients with nephrotic syndrome and systemic lupus erythematosus in a 1∶1 way were divided into observation group (40 cases)and control group (40 cases) by random number table method. The control group received conventional treatment without clinical pharmaceutical care, and the observation group received conventional treatment with clinical pharmaceutical care, then the compliance, efficacy and adverse drug reactions between two groups were analyzed. Results Compared with the control group, the observation group had more understanding of the diseases,medicines and the drug compliance, the differences were statistically significant (P＜0.05). The renal function was improved, and the urinary protein decreased or negative urine patients were more than those in control group, the difference was statistically significant(P＜0.05). The main adverse drug reactions were Cushingoid features, with an incidence of more than 60%, but there was no significant difference between two groups (P＞0.05). However, the incidence of insomnia adverse reactions in the observation group was lower than that in the control group, the difference was statistically significant (P＜0.05). Conclusion The clinical pharmacists participated in the pharmaceutical care of patients with long-term use of Glucocorticoids could promote their understanding of the diseases and medicines, drug compliance,improve renal function and reduce the occurrence of adverse reactions such as insomnia.

Key words： Glucocorticoids Pharmaceutical care Nephrotic syndrome Systemic lupus erythematosus

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZENG Yan-cong
	HUANG Shuang-ying
	WU Di

Cite this article:

ZENG Yan-cong,HUANG Shuang-ying,WU Di. Effect analysis of clinical pharmacists participating in the pharmaceutical care of patients with long-term use of Glucocorticoids[J]. 中国当代医药, 2021, 28(3): 17-20.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I3/17

[1]	卫生部办公厅．糖皮质激素类药物临床应用指导原则（卫办医政发[2012]23 号[EB/OL]．http：//www.gov.cn/gzdt/2011-02/24/content_1810219.htm．[2011-02-16].
[2]	王肇辉，解红霞．糖皮质激素的药理作用及在肾脏病中的应用与进展[J]．医学综述，2017，23（9）：1815-1820．
[3]	王海燕．肾脏病临床概览[M]．北京：北京大学医学出版社，2010：121-168．
[4]	黄玉琼，张亚敏，陶娟．糖皮质激素在系统性红斑狼疮中的应用及研究现状[J]．皮肤科学通报，2018，35（3）：296-304．
[5]	中国系统性红斑狼疮研究协作组专家组．糖皮质激素在系统性红斑狼疮患者合理应用的专家共识[J]．中华内科杂志，2014，53（6）：502-504．
[6]	龙红英，胡延毅．糖皮质激素长期用于肾病综合征治疗中的不良反应分析[J]．基层医学论坛，2018，22（13）：1765-1766．
[7]	冷亚东．糖皮质激素类药物的不良反应和并发症的分析研究[J]．北方药学，2017，14（1）：154．
[8]	Calis KA，Hutchison LC，Elliot ME，et al．Healthy people 2010：challenges，opportunities，and a call to action for America′s pharmacists[J]．Pharmacotherapy，2004，24（9）：1241-1294．
[9]	胡洁茹，傅军霞，叶伟红．药学监护在持续使用糖皮质激素患者中的应用效果[J]．中国乡村医药，2018，25（18）：39-40．
[13]	何娅妮，张炜炜.肾病综合征的流行病学现状[J].中华肾病研究电子杂志，2017，6（4）：149-153.
[14]	陆前进，罗帅寒天．系统性红斑狼疮的诊疗进展[J]．中华皮肤科杂志，2018，51（1）：1-4．
[15]	陈卫东．肾病综合征并发特发性急性肾功能衰竭治疗分析[J]．中国医药科学，2012，2（3）：87-89．
[16]	Wang CS，Greenbaum LA．Nephrotic Syndrome[J]．Pediatr Clin North Am，2019；66（1）：73-85．
[17]	荆欣欣，王大海，郭兴青，等．儿童与成人系统性红斑狼疮的临床特点分析[J]．临床医学进展，2019，9（1）：80-87．
[10]	Morisky DE，Green LW，Levine DM．Concurrent and predictive validity of a self-reported measure of medication adherence[J]．Medical Care，1986，24（1）：67-74．
[11]	Patel DA，Kristensen PL，Pedersen-Bjergaard U，et al．Glucocorticoid-induced diabetes and risk factors during highdose therapy[J]．Ugeskr Laeger，2018，30；180（18）：V06170 454．
[12]	Waljee AK，Rogers MA，Lin P，et al．Short term use of oral corticosteroids and related harms among adults in the United States：population based cohort study[J]．BMJ，2017，357：j1415．
[18]	何梦静，周威．糖皮质激素的临床应用[J]．中国临床研究，2018，31（5）：679-681．
[19]	于晶．糖皮质激素联合环磷酰胺治疗重症系统性红斑狼疮的效果[J]．中国当代医药，2018，25（10）：44-46．
[20]	Rodenbeck A，Huether G，Rüther E，et al．Interactions between evening and nocturnal cortisol secretion and sleep parameters in patients with severe chronic primary insomnia[J]．Neurosci Lett，2002，324（2）：159-163．